Home
Conditions
Hepatitis, Viral, Human

Clinical trial condition

Hepatitis, Viral, Human

Explore clinical trials studying Hepatitis, Viral, Human. Study availability and eligibility vary by location and protocol.

2,934 public trials 160 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Viral, Human trial results

Completed

Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults

NCT00697242

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Vienna, Austria

GSK Clinical Trials Call Center Ghent, Belgium

GSK Clinical Trials Call Center Hvidovre, Denmark

GSK Clinical Trials Call Center Reykjavik, Iceland

View Trial Details

Completed

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

NCT00696891

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Wilrijk, Belgium

GSK Clinical Trials Call Center Toronto, Canada

GSK Clinical Trials Call Center Gothenburg, Sweden

View Trial Details

Completed

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

NCT00697125

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Ghent, Belgium

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

NCT00697216

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Brussels, Belgium

GSK Clinical Trials Call Center Copenhagen, Denmark

View Trial Details

Completed

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

NCT00697229

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Wilrijk, Belgium

View Trial Details

Completed

Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C

NCT00343525

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: University Hepatitis Center at Bach & Godofsky MD PA Sarasota, Florida, United States

Alamo Medical Research San Antonio, Texas, United States

View Trial Details

Completed

Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection

NCT00128271

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Bach & Godofsky, MD, PA Bradenton, Florida, United States

View Trial Details

Completed

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

NCT00266318

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Beth Israel Medical Center New York, United States

View Trial Details

Completed

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

NCT00314054

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Gainesville, Florida, United States

Orlando, Florida, United States

Saint Paul, Minnesota, United States

View Trial Details

Completed

PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients

NCT00644761

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Cedars Sinai Medical Center Los Angeles, California, United States

California Pacific Medical Center San Francisco, California, United States

University of California, San Francisco San Francisco, California, United States

View Trial Details

Hepatitis, Viral, Human

Hepatitis, Viral, Human trial results

Related conditions